Insulin-like growth factor-1 receptor (IGF-1R)
Showing 1 - 25 of >10,000
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
-
Los Angeles, California
- +1 more
Mar 17, 2022
Acute Kidney Injury (Nontraumatic), Pneumoperitoneum Trial (IGF-1)
Not yet recruiting
- Acute Kidney Injury (Nontraumatic)
- Pneumoperitoneum
- IGF-1
- (no location specified)
Nov 8, 2022
Insulin Like Growth Factor-1 Against Oxidative Stress in
Not yet recruiting
- Vitiligo
- skin biopsy examined by ELISA technique
- (no location specified)
Apr 13, 2023
UVB Phototherapy Burn, Insulin-like Growth Factor 1, Aging Trial in Fairborn (Insulin-Like Growth Factor 1, No Insulin-Lie
Recruiting
- UVB Phototherapy Burn
- +2 more
- Insulin-Like Growth Factor 1
- No Insulin-Lie Growth Factor 1
-
Fairborn, OhioWright State Physicians
Jan 9, 2023
Cancer, Overweight and Obesity Trial (Aerobic Exercise)
Not yet recruiting
- Cancer
- Overweight and Obesity
- Aerobic Exercise
- (no location specified)
Dec 13, 2022
Relation Between Serum IGF-1 & BMI In Acne Vulgaris
Not yet recruiting
- Evaluation of Serum Level of Insulin Like Growth Factor 1
- (no location specified)
Aug 16, 2022
Malignant Glioma, Tumors Trial in Philadelphia (IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion
Completed
- Malignant Glioma
- Neoplasms
- IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours.
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Oct 5, 2020
22q13 Deletion Syndrome, Phelan-McDermid Syndrome Trial in New York (Insulin-Like Growth Factor-1 (IGF-1), Normal saline)
Completed
- 22q13 Deletion Syndrome
- Phelan-McDermid Syndrome
- Insulin-Like Growth Factor-1 (IGF-1)
- Normal saline
-
New York, New YorkSeaver Austin Center, Icahn School of Medicine at Mount Sinai
Apr 18, 2022
Tendinopathy, Patellar Ligament, Platelet-Rich Plasma Trial in Columbus (Platelet Rich Plasma, Platelet Rich Plasma plus IGF)
Completed
- Tendinopathy
- +2 more
- Platelet Rich Plasma
- Platelet Rich Plasma plus IGF
-
Columbus, OhioThe Ohio State University Sports Medicine Center
Aug 4, 2022
Anorexia Nervosa Trial in Boston (RhIGF-1)
Completed
- Anorexia Nervosa
-
Boston, MassachusettsMassachusetts General Hospital
Oct 22, 2021
Health Status of Children Born After Assisted Reproductive
Recruiting
- Children Born After Assisted Reproductive Technologies
- +2 more
- hemogram examination
-
Almaty, KazakhstanSevara ilmuratova
Oct 17, 2023
Insulin Growth Factor I Deficiency, IGF1 Deficiency, Executive Function Disorder Trial in Seville (HIIT, HIIT+PA, CON)
Recruiting
- Insulin Growth Factor I Deficiency
- +2 more
- HIIT
- +2 more
-
Seville, SpainEducation Faculty
Nov 30, 2022
Growth Hormone in EB
Not yet recruiting
- Epidermolysis Bullosa Dystrophica
- growth hormone level and insulin like growth factor 1
- (no location specified)
May 24, 2022
Disorder of Bone Density and Structure, Unspecified Trial in Boston (Recombinant human insulin like growth factor-1 (rhIGF-1))
Completed
- Disorder of Bone Density and Structure, Unspecified
- Recombinant human insulin like growth factor-1 (rhIGF-1)
-
Boston, MassachusettsMassachusetts General Hospital
Oct 22, 2021
Acne Vulgaris Trial (Topical Metformin Emulgel and salicylic acid, Insulin- Like growth factor (ILGF-1))
Not yet recruiting
- Acne Vulgaris
- Topical Metformin Emulgel and salicylic acid
- Insulin- Like growth factor (ILGF-1)
- (no location specified)
Sep 7, 2022
AR, IGF-IR, IR and Peripheral Artery Disease
Recruiting
- Androgen Receptor Abnormal
- +2 more
- arterial reconstructive open surgery
-
Catanzaro, ItalyUniversity Magna Graecia of Catanzaro
Jan 12, 2021
Pre-frail Elderly Trial in Jakarta (Cholecalciferol, Placebo)
Completed
- Pre-frail Elderly
- Cholecalciferol
- Placebo
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo General Hospital
Jan 25, 2023
Ataxia, Spinocerebellar, Insulin-Like Growth Factor I, Medicine, Chinese Traditional Trial in Changhua (Chinese medicine WT)
Recruiting
- Ataxia, Spinocerebellar
- +2 more
- Chinese medicine WT
-
Changhua, TaiwanChanghua Christian Hospital
Oct 22, 2021
Insulin-Like Growth Factor I, Healthy Trial in London (Amino Acid Supplement, Placebo)
Recruiting
- Insulin-Like Growth Factor I
- Healthy
- Amino Acid Supplement
- Placebo
-
London, Ontario, CanadaKGK Science Inc.
Jan 9, 2023
Myotonic Dystrophy Type 1 Trial in United States (rhIGF-I/rhIGFBP-3, )
Completed
- Myotonic Dystrophy Type 1
- rhIGF-I/rhIGFBP-3
- placebo
-
Orange, California
- +11 more
Dec 8, 2021
A Pan-European Post-Authorisation Safety Study: Risk of
Not yet recruiting
- Pancreatic Cancer
- Exenatide
- Non-GLP-1 RA based glucose lowering drugs
- (no location specified)
Dec 21, 2022
Diabetes, Diabetic Kidney Disease Trial in Sha Tin (Dulaglutide, Insulin Degludec, Continuous glucose monitor)
Recruiting
- Diabetes Mellitus
- Diabetic Kidney Disease
- Dulaglutide
- +2 more
-
Sha Tin, Hong KongPrince of Wales Hospital
Nov 8, 2022